The Experts in Animal Health

Brakke Consulting’s
Animal Health News & Notes for January 26, 2018
Copyright © Brakke Consulting, Inc.

Editor: Lynn Fondon DVM MBA


Brakke Consulting news
Equine Mega Study IV – now available!
2018 Industry Overview – last week to register for VMX Overview

earnings news
Benchmark Holdings
Hester Biosciences
Jaguar Health
PetMed Express

other news
Aptimmune Biologics
Archer Daniels Midland
AST Farma
Dechra (Premune)
Dechra (AST Farma and Le Vet)
Hagyard Equine Medical Institute
Laboratorios Hipra
Le Vet
Phyto Animal Health
Qingdao Vland Biotech
Quay Pharma
The Pet Vet


Brakke Consulting announces the publication of the fourth edition of the Equine Market MegaStudy, a comprehensive study of horse owner buying and decision-making behavior. This highly popular survey includes over 400 brands of equine products in 17 categories. The study also measures readership of equine publications, catalogs and websites, and provides a wealth of information on horse owner demographics and segments.

The cost of the report is $15,000.  For more information, or to order a study, contact John Volk, Senior Consultant,, (773) 327-4941.


  • Vetoquinol reported results for the full year 2017. Total sales were EUR 352 million ($422 million), an increase of 0.5% compared to the prior year (+1% at constant exchange rates). (company website) 
  • Colgate-Palmolive Company reported results for the full year 2017. Sales for Hill’s Pet Nutrition were $2,292 million, an increase of 1% compared to the prior year. Hill’s operating profit was $653 million, unchanged from the prior year. (company press release) 
  • Abaxis, Inc. reported financial results for the third fiscal quarter ended December 31, 2017. Revenues were $60 million, up 13% over last year’s comparable quarter. Net income was $4.2 million compared to $6.8 million in the comparable prior-year period. Veterinary market revenues were $48 million, up 12% over last year’s comparable quarter. (PRNewswire) 
  • PetMed Express, Inc. announced its financial results for the fiscal third quarter ended December 31, 2017. Net sales for the quarter were $60 million, an increase of 14%. Net income was $9.1 million compared to net income of $4.8 million in the comparable prior-year quarter. (company website) 
  • Animalcare reported unaudited results in a like-for-like comparison using a pro forma 12-month period to December 31, 2017. The combined companies (Animalcare and Ecuphar) recorded revenues of around GBP 92 million ($128 million), representing year-on-year growth of 9.5%. (Animal Pharm) 
  • Hester Biosciences reported results for the third quarter of fiscal 2018. Revenues reached INR 319.25 million ($5 million) in quarter, a 10% year-on-year improvement in sales. The firm also reported a 12% increase in third-quarter net profit to INR 65 million ($1.0 million). (Animal Pharm) 
  • Benchmark Holdings reported results for the full year ended September 2017. Sales in the animal health division decreased from GBP 24.8 million to GBP 15.1 million ($21 million) as a result of drop in sales of the sea lice treatment Salmosan. (TheFishSite) 
  • Jaguar Health reported results for the full year 2017. Net sales in 2017 for Jaguar’s non-prescription Neonorm Foal and Neonorm Calf products totaled approximately $422,000. Animal Health collaboration revenue totaled approximately $2.9 million. (company press release)


The KC Animal Health Corridor is now accepting applications to present at the 2018 KC Animal Health Investment Forum on August 21 in Kansas City, Missouri.

Now in its 10th year, the Forum is one of the only opportunities in the world for early-stage companies in the animal health sector to present their vision, business plan and technology to potential investors.

The selection committee will consider companies that meet the following criteria:

– Seeking $500,000 – $20 million in funding
– Revenue projections of $20 million within 5-7 years

Applications are due on April 6. To apply, go to

For more information, contact Kimberly Young at


  • Elanco Animal Health announced the approval of Credelio, a monthly oral tick and flea treatment for dogs that contains the patented active ingredient lotilaner. Credelio will be available in four chewable tablet strengths for dogs and is approved for puppies and dogs from eight weeks of age and older and 4.4 pounds and greater. (PRNewswire) 
  • Dechra Veterinary Products announced an agreement with Premune to add Premune’s Redonyl Ultra, a new palatable veterinary nutraceutical to support healthy skin function, to Dechra’s existing topical dermatology portfolio in North America. (company press release) 
  • Abaxis, Inc. announced that the USDA Center for Veterinary Biologics approved its new VetScan FLEX4 Rapid Test for veterinary use. The FLEX4 is a 4-in-1 lateral flow test used for the qualitative detection of Heartworm antigen as well as antibodies for Lyme, Ehrlichia and Anaplasma in canine whole blood, serum, or plasma samples. (Business Insider) 
  • Aptimmune Biologics announces it has completed its Series B funding initiative, raising more than $6 million from several investors. In addition, the company is relocating its headquarters and laboratory from Champaign, Illinois, to the Bio-Research & Development Growth Park in St. Louis, Missouri. (National Hog Farmer) 
  • Medical Marijuana, Inc. announced the establishment of its newest subsidiary, Phyto Animal Health. Phyto Animal Health offers a line of cannabidiol (CBD) hemp oil supplements and hemp products targeted to cats, dogs and horses. ( 
  • Petco announced that, in addition to in-store veterinary services offered by THRIVE, it is also adding veterinary hospitals operated by The Pet Vet. Each Pet Vet hospital offers full-service medical and urgent care seven days a week, as well as a comprehensive wellness plan for every stage of a pet’s life. (Vet Advantage) 
  • Archer Daniels Midland (ADM) announced an agreement with Chinese company Qingdao Vland Biotech for enzymes for animal feed. Both companies will share enzyme-producing strains as a foundation for the development of feed enzymes designed to improve animal nutrition and health. Any products developed under the agreement will be commercialized by both firms. (Animal Pharm) 
  • Quay Pharma, which provides pharmaceutical development and clinical manufacturing services to the global biotech-pharmaceutical industry, has been awarded a full license to extend its capabilities into veterinary medicine. The company’s pharmaceutical outsourcing specialist is working on a project for a new range of feline liquid medications. The first commercial launch of products is expected early this year. (American Veterinarian) 
  • Mixed Animal Veterinary Associates of North America (MAVANA) announced that Hagyard Equine Medical Institute in Lexington, Ky. has merged with MAVANA. MAVANA is comprised of 22 equine, mixed animal and companion animal veterinary practices across 11 states. ( 
  • Petrics, Inc. announced the launch of “the world’s first Smart Pet Bed, Activity Tracker, and pet Health and Nutrition App.” The system tracks a pet’s weight, activity levels, rest periods and offers climate control to keep pets in optimal comfort and safety within varying climates and seasons. (Vet Advantage) 
  • NETHERLANDS Dechra announced it will acquire Netherlands-based AST Farma and Le Vet for a total of EUR 340 million ($407 million) in a cash-and-share deal. AST Farma is an animal pharmaceuticals firm that specializes in generic products, while Le Vet focuses on the European markets outside of the Netherlands. The firms have worked together and hold around 90 product registrations. ( 
  • CANADA Laboratorios Hipra announced it has received approval in Canada for Evalon, a coccidiosis vaccine for chickens.  It is the company’s first Canadian approval for an avian vaccine. (Animal Pharm) 
  • UK Felcana announced that it has received seed funding from InseadAlum Ventures (IAV), a Singapore-headquartered investment firm founded. Founded in 2015, Felcana develops technologies that innovates across the pet healthcare and veterinary medicine industry by providing a holistic digital approach to pet health. The financing will be used to launch the Company’s first product, the Health Monitoring Kit, with global roll-out. (GlobalPets)


  • US – EQUINE HERPES The University of Pennsylvania’s New Bolton Center announced a self-imposed equine quarantine for equine herpes myeloencephalitis (EHM). New Bolton canceled all elective, equine appointments pending further instructions from the regional state veterinarian and will receive equine or camelid emergency admissions only during this time. (Vet Advantage) 
  • US – CANINE INFLUENZA A recent cluster of canine influenza cases in San Francisco has triggered reports that the dog flu has spread nationwide. However, according to experts at the AVMA and Cornell University College of Veterinary Medicine, there’s no evidence that it’s spreading across the country.  Cornell’s Animal Health Diagnostic Center said recent laboratory testing shows dog flu in only two regions: northern Kentucky/southern Ohio and central California. According to experts, the virus infects dogs in a given city and tends to die out over a few months. (, USA Today) 
  • US – HOG SLAUGHTER USDA Food Safety and Inspection Service (FSIS) is proposing to amend the federal meat inspection regulations to establish a new voluntary inspection system for market hog slaughter establishments called the New Swine Slaughter Inspection System (NSIS), while also requiring additional pathogen sampling for all swine slaughter establishments. (Vet Advantage) 
  • US – AIRLINE REGULATIONS Delta Air Lines announced it will soon require owners of service and support animals to provide more information before their animal can fly in the passenger cabin, including an assurance that it’s trained to behave itself. Delta’s new rules are aimed at two categories: service animals, which receive specific training to help blind or disabled passengers; and so-called emotional-support animals, which require no training at all. Both fly for free and are not required to be caged during the flight. The new requirements don’t apply to pets, for which owners pay an extra fee. (


Brakke Consulting is pleased to announce the 2018 Industry Overview. The 2018 US Animal Health Industry Overview will be presented twice this winter – once at the VMX (formerly NAVC) in Orlando, Florida and once at the Western Veterinary Conference in Las Vegas, Nevada. These dates are:
• VMX: Monday, February 5, 2018, 2:00 – 4:00 pm, Rosen Plaza Hotel
• WVC: Tuesday, March 6, 2018, 2:00 – 4:00 pm, Four Seasons.

Registration for the VMX Industry Overview is now open; registration for the WVC Industry overview will open in January. Seating is limited this year, so register early!

To register, go to and scroll down to the “What’s New” box. The price is $400 per person for online registration; late registration is $450.


Dear readers, have you ever attended a Brakke Consulting Animal Health Industry Overview?  Hopefully the answer is yes, because we’ve been producing and presenting the industry overview for 30-plus years.  If you have not attended one you’ve missed some great sessions and information that we’ve provided to thousands of industry managers at conferences or in their companies’ conference rooms.

I want to encourage each of you to consider attending the 2018 Industry Overview for two reasons.  First, it might well be the last “Brakke Industry Overview” because this spring we’ll be joining forces with Stonehaven Consulting.  (Will there be a “Stonehaven & Brakke Industry Overview” next year? Stay tuned!)  Second, this year’s overview focuses on several trends that will be challenging for the industry, not only in 2018 but in future years.

We still have space available in both the VMX and WVC overviews but we do have limited room, so at some point we will be closing registrations – VMX registration closes next Friday if not sold out before that.  We look forward to seeing you at one of the overviews so we can provide you with not only our views on industry trends, but also about the future consulting activities of a combined Brakke and Stonehaven Consulting.  Don’t miss this opportunity for what may be the last “Brakke Industry Overview”!

Have a great weekend!

Ron Brakke


Trouble viewing this newsletter?  You can view it online at

This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.

For more information about Brakke Consulting’s services and syndicated studies, visit our website at

Brakke Consulting, Inc.
12005 Ford Rd., Suite 530
Dallas, TX  75234    USA


en_USEnglish (United States)